Table 2 Analysis of postoperative muscle relaxation monitoring and patient recovery
Control group | Neostigmine groups | |||||
|---|---|---|---|---|---|---|
NS (n = 47) | 20 µg/kg (n = 49) | 40 µg/kg (n = 50) | 50 µg/kg (n = 50) | H or X2 | P | |
time of TOF ≥ 90% after neostigmine (min) | 22 (18,38) | 13 (10,15.8) | 8 (7,11) | 7 (6,8) | 104.257 | < 0.001* |
TOF value 10 min after neostigmine (%) | 60 (50,71) | 80 (72,96) | 96 (86.5,100) | 100 (95,100) | 93.351 | < 0.001* |
PACU stay time after neostigmine (min) | 62 (45,69) | 56.5 (47,65) | 51 (45,69.5) | 45 (35,57) | 10.671 | 0.014* |
postoperation hospital stay (d) | 7 (6,10) | 7 (5,9) | 7 (5,11.5) | 7 (6,10) | 0.552 | 0.907 |
MMSE score | -1 (-2,0) | -1 (-1.75,1) | 0 (-2,1) | -1 (-1,1) | 0.397 | 0.941 |
PONV (n,%) | 12 (25.5%) | 8 (16.3%) | 7 (14.0%) | 13 (26.0%) | 3.489 (X2) | 0.322 |